15. Inclusion body myositis Clinical trials / Disease details


Clinical trials : 42 Drugs : 60 - (DrugBank : 16) / Drug target genes : 12 - Drug target pathways : 123

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2007-004359-12-IT
(EUCTR)
05/04/200721/11/2007Simvastatin treatment in inclusion body myositis (IBM) - NDSimvastatin treatment in inclusion body myositis (IBM) - ND INCLUSION BODY MYOSITIS
MedDRA version: 6.1;Level: PT;Classification code 10028289
Trade Name: SIVASTIN
INN or Proposed INN: Simvastatin
INN or Proposed INN: Immunoglobulins, normal human, for intravascular adm.
ISTITUTO NEUROLOGICO CARLO BESTANULLNot RecruitingFemale: yes
Male: yes
Italy
2EUCTR2006-005942-35-IT
(EUCTR)
14/03/200704/06/2007Simvastatin therapy in IBM - NDSimvastatin therapy in IBM - ND inclusion body myositis
MedDRA version: 6.1;Level: PT;Classification code 10028641
Trade Name: SIVASTIN
INN or Proposed INN: Simvastatin
Trade Name: FLEBOGAMMA 5%
INN or Proposed INN: Immunoglobulins, normal human, for intravascular adm.
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLINULLNot RecruitingFemale: yes
Male: yes
Italy